Hepatic epithelioid hemangioendothelioma: Clinical characteristics, diagnosis, treatment, and prognosis

Table 2 Treatments and prognosis of patients with hepatic epithelioid hemangioendothelioma

Treatment and outcome, n = 118	n (%)	Mean survival time in months, mean ± SD
LR	35 (29.7)	158.6 ± 20.5
LT	19 (16.1)	147.3 ± 13.8
Palliative treatment	15 (12.7)	4.2 ± 0.8
TACE	12 (10.2)	90.8 ± 13.4
Chemotherapy	13 (11.0)	71.4 ± 23.5
Other treatments	6 (5.1)	55.0 ± 17.0
Antiangiogenic therapy	18 (15.3)	83.1 ± 9.7

LR: Liver resection; LT: Liver transplantation; TACE: Transhepatic arterial chemotherapy and embolization.